Pfizer is in a unique position in its history with gushers of cash flowing in from everywhere. 

Pfizer will use this cash to power future growth through its drug pipeline, innovation, and acquisitions

which will secure promising returns and profitability for investors in the year ahead. 

Pfizer is definitely one of the most attractive healthcare investments around. 

I wrote this article myself, and it expresses my own opinions. 

I am not receiving compensation for it (other than from Seeking Alpha).  

I have no business relationship with any company whose stock is mentioned in this article. 

– Since I rated Pfizer as a Strong Buy on the 8th of February 2021, the shares have returned 43% for investors.

– The company has reinvented itself, and is enjoying one of the best periods of its history.

– Valuation is compelling, and growth prospects are strong.

– The selling of its stake in GSK’s consumer healthcare venture will generate even more cash to power growth.